Comparison of hemodialysis and peritoneal dialysis in the management of anemia related to chronic renal disease.

Abstract:

:A number of conditions can contribute to the development of the anemia that inevitably occurs with end-stage renal disease. The primary ones are decreased production of erythropoietin (EPO), decreased response to EPO by the bone marrow, and shortened red cell survival. Dialysis improves hematocrit levels by reducing plasma volume and by increasing red cell mass as a result of clearing some of the middle molecule uremic toxins that affect EPO efficiency and red cell survival time. Patients undergoing continuous ambulatory peritoneal dialysis generally show higher hematocrits and lower transfusion dependencies than hemodialysis patients. The development of recombinant human EPO (EPOGEN, AMGEN Inc, Thousand Oaks, CA) largely ends the transfusion dependence of hemodialysis patients and may prove efficacious in those patients who are not transfusion dependent but whose low hematocrit levels may cause debilitating symptoms.

journal_name

Semin Nephrol

journal_title

Seminars in nephrology

authors

Korbet SM

subject

Has Abstract

pub_date

1989-03-01 00:00:00

pages

9-15

issue

1 Suppl 1

eissn

0270-9295

issn

1558-4488

journal_volume

9

pub_type

杂志文章,评审
  • Pediatric nephrotic syndrome: from the simple to the complex.

    abstract::Remarkable advances have been made in the past decade in understanding the pathophysiology of idiopathic nephrotic syndrome. Although the initiating events leading to the onset of proteinuria still are not well defined, it has become increasingly clear that many glomerular diseases can be classified as podocytopathies...

    journal_title:Seminars in nephrology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semnephrol.2009.03.015

    authors: Lane JC,Kaskel FJ

    更新日期:2009-07-01 00:00:00

  • Urban renal disease: reflections of an urban nephrologist.

    abstract::On completion of a Nephrology fellowship, I went back to the inner city community where I was raised to begin my practice. Filled with idealism, I believed that, by returning, I could slow the devastation that hypertension was imparting on the black community, and in doing so, prevent end-stage renal disease (ESRD). I...

    journal_title:Seminars in nephrology

    pub_type: 杂志文章

    doi:10.1053/snep.2001.23688

    authors: Crawford PW

    更新日期:2001-07-01 00:00:00

  • Clinical presentation, natural history, and treatment of crescentic proliferative IgA nephropathy.

    abstract::IgA nephropathy is one of the most common causes of glomerulonephritis in the world and is characterized histologically by the deposition of polymeric forms of IgA within the mesangium and in some cases along the glomerular capillary wall.(1) Proliferative and crescenteric forms of IgA are associated with nephrotic ra...

    journal_title:Seminars in nephrology

    pub_type: 杂志文章

    doi:10.1016/j.semnephrol.2004.01.006

    authors: Tumlin JA,Hennigar RA

    更新日期:2004-05-01 00:00:00

  • Prospective studies of diagnosis and intervention: the Dutch experience.

    abstract::This prospective multicenter study included 1,205 patients, who were referred for difficult-to-treat hypertension or analysis of possible secondary hypertension. After a standardized selection protocol based on sharply defined drug-resistant hypertension or renal function impairment during angiotensin-converting enzym...

    journal_title:Seminars in nephrology

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:

    authors: van Jaarsveld BC,Krijnen P

    更新日期:2000-09-01 00:00:00

  • Treatment of hypertension.

    abstract::Effectiveness of antihypertensive agents is assessed not only by systemic blood pressure levels, but by multiple parameters that reflect specific organ functions. Among antihypertensive agents, those which inhibit angiotensin actions show particular efficacy in ameliorating end organ damage. This efficacy likely refle...

    journal_title:Seminars in nephrology

    pub_type: 杂志文章,评审

    doi:

    authors: Fogo A,Kon V

    更新日期:1996-11-01 00:00:00

  • A systems biology preview of the relationships between mineral and metabolic complications in chronic kidney disease.

    abstract::There are emerging data that the skeleton is connected to systemic biological functions through the release of two osteoblast-/osteocyte-derived hormones, fibroblastic growth factor 23 (FGF23) and undercarboxylated osteocalcin (Ocn). FGF23 is important in the regulation of phosphate and vitamin D metabolism, whereas O...

    journal_title:Seminars in nephrology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semnephrol.2012.12.014

    authors: Quarles LD

    更新日期:2013-03-01 00:00:00

  • Vasopressor Therapy and Blood Pressure Management in the Setting of Acute Kidney Injury.

    abstract::Acute kidney injury (AKI) is common in the setting of shock. Hemodynamic instability is a risk factor for the development of AKI, and pathophysiological mechanisms include loss of renal perfusion pressure and impaired microcirculation. Although restoration of mean arterial pressure (MAP) may mitigate the risk of AKI t...

    journal_title:Seminars in nephrology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semnephrol.2019.06.006

    authors: Busse LW,Ostermann M

    更新日期:2019-09-01 00:00:00

  • The role of autoantibodies in the pathogenesis of lupus nephritis.

    abstract::Despite intensive research over the past three decades, the events leading to pathogenic autoantibody production and immune deposit formation in individuals with systemic lupus erythematosus continues to be debated. The controversy is fueled by the clinical observations that individual patients with lupus have variabl...

    journal_title:Seminars in nephrology

    pub_type: 杂志文章,评审

    doi:

    authors: Madaio MP

    更新日期:1999-01-01 00:00:00

  • Hemodynamics of hyperuricemia.

    abstract::Prolonged hyperuricemia is associated with the development of hypertension, renal arteriolosclerosis, glomerulosclerosis, and tubulointerstitial injury. It confers a greater risk than proteinuria for developing chronic renal disease and is associated with the development of hypertension. Mild chronic hyperuricemia wit...

    journal_title:Seminars in nephrology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semnephrol.2004.09.004

    authors: Sánchez-Lozada LG,Tapia E,Rodríguez-Iturbe B,Johnson RJ,Herrera-Acosta J

    更新日期:2005-01-01 00:00:00

  • Neutrophil gelatinase-associated lipocalin curve and neutrophil gelatinase-associated lipocalin extended-range assay: a new biomarker approach in the early diagnosis of acute kidney injury and cardio-renal syndrome.

    abstract::Cardio-Renal syndrome (CRS) is a common and complex clinical condition in which multiple causative factors are involved. The time window between renal insult and development of acute kidney injury (AKI) in acute heart failure (AHF) can be varied in different patients and AKI often is diagnosed too late, only when the ...

    journal_title:Seminars in nephrology

    pub_type: 杂志文章

    doi:10.1016/j.semnephrol.2011.11.015

    authors: Ronco C,Cruz D,Noland BW

    更新日期:2012-01-01 00:00:00

  • Antiphospholipid Syndrome and the Kidney.

    abstract::The antiphospholipid syndrome (APS) is a systemic autoimmune disorder characterized by a combination of arterial and/or venous thrombosis, pregnancy morbidity, and the persistent presence of circulating antiphospholipid antibodies (aPL). APS has been described as primary APS when it occurs in the absence of any featur...

    journal_title:Seminars in nephrology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semnephrol.2015.08.009

    authors: Sciascia S,Baldovino S,Schreiber K,Solfietti L,Roccatello D

    更新日期:2015-09-01 00:00:00

  • Renal reserve in patients with solitary kidneys.

    abstract::The first part of this article focuses on the risk of functional deterioration in subjects with solitary kidneys; the long-term clinical outcome of various subgroups of patients is reviewed. Thereafter, the pathophysiology of the renal functional reserve in subjects with a 50% reduction in renal parenchyma and the res...

    journal_title:Seminars in nephrology

    pub_type: 杂志文章,评审

    doi:

    authors: Rugiu C,Oldrizzi L,Maschio G

    更新日期:1995-09-01 00:00:00

  • Creating research infrastructure and functionality to address chronic kidney disease: the Kidney Research Institute.

    abstract::An expanding proportion of people in the United States and worldwide are affected by kidney disease, leading to a growing concern over the public health implications. Despite the high prevalence and the considerable associated health risks of kidney disease, major gaps in our knowledge base hinder the delivery of opti...

    journal_title:Seminars in nephrology

    pub_type: 评论,杂志文章,评审

    doi:10.1016/j.semnephrol.2009.06.002

    authors: Himmelfarb J,Shankland SJ

    更新日期:2009-09-01 00:00:00

  • Role of Mesangial-Podocytic-Tubular Cross-Talk in IgA Nephropathy.

    abstract::IgA nephropathy (IgAN), a common primary glomerulonephritis worldwide, is associated with a substantial risk of progression to end-stage renal failure. The disease runs a highly variable clinical course with frequent involvement of tubulointerstitial damage. A subgroup of IgAN with proximal tubular epithelial cells (P...

    journal_title:Seminars in nephrology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semnephrol.2018.05.018

    authors: Leung JCK,Lai KN,Tang SCW

    更新日期:2018-09-01 00:00:00

  • Stroke and Chronic Kidney Disease: Epidemiology, Pathogenesis, and Management Across Kidney Disease Stages.

    abstract::Cerebrovascular disease and stroke are very common at all stages of chronic kidney disease (CKD), likely representing both shared risk factors as well as synergy among risk factors. More subtle ischemic brain lesions may be particularly common in the CKD population, with subtle manifestations including cognitive impai...

    journal_title:Seminars in nephrology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semnephrol.2015.06.003

    authors: Dad T,Weiner DE

    更新日期:2015-07-01 00:00:00

  • Epidemiology of chronic kidney disease in cancer patients: lessons from the IRMA study group.

    abstract::Kidney disease has been shown to be highly prevalent in cancer patients in the IRMA studies (Renal Insufficiency and Anticancer Medications). Furthermore, anticancer drugs used in those patients, among which half have abnormal renal function, necessitate dosage adjustment in case of reduced renal function and/or is po...

    journal_title:Seminars in nephrology

    pub_type: 杂志文章

    doi:10.1016/j.semnephrol.2010.09.003

    authors: Launay-Vacher V

    更新日期:2010-11-01 00:00:00

  • The treatment of idiopathic membranous nephropathy.

    abstract::Membranous nephropathy remains the most common cause of the nephrotic syndrome in adults. Most patients do well with long-term natural history studies reporting a 10-year renal survival of 70% to 90% but the remainder progress to end stage renal failure. This plus the associated morbidity of those with persistent high...

    journal_title:Seminars in nephrology

    pub_type: 杂志文章,评审

    doi:

    authors: Geddes CC,Cattran DC

    更新日期:2000-05-01 00:00:00

  • Role of sodium restriction and diuretic therapy for "resistant" hypertension in chronic kidney disease.

    abstract::In patients with chronic kidney disease, an impaired capacity of the kidney to excrete sodium is a major contributor to hypertension. We discuss the role of sodium restriction and diuretic therapy for resistant hypertension in chronic kidney disease. Independent of increasing blood pressure, a sustained high sodium in...

    journal_title:Seminars in nephrology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semnephrol.2014.08.005

    authors: Sinnakirouchenan R,Kotchen TA

    更新日期:2014-01-01 00:00:00

  • Sepsis-associated acute kidney injury: macrohemodynamic and microhemodynamic alterations in the renal circulation.

    abstract::Traditionally, renal ischemia has been regarded as central to the pathogenesis of sepsis-associated acute kidney injury (SA-AKI). Accordingly, hemodynamic management of SA-AKI has emphasized restoration of renal perfusion, whereas, experimentally, ischemia reperfusion models have been emphasized. However, in human bei...

    journal_title:Seminars in nephrology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semnephrol.2015.01.007

    authors: Prowle JR,Bellomo R

    更新日期:2015-01-01 00:00:00

  • Inherited hypercalciuric syndromes: Dent's disease (CLC-5) and familial hypomagnesemia with hypercalciuria (paracellin-1).

    abstract::Dent's disease and familial hypomagnesemia with hypercalciuria and nephrocalcinosis (FHHNC) are inherited diseases in which hypercalciuria, nephrocalcinosis, and renal failure are prominent features. Dent's disease resembles a Fanconi syndrome, with impaired reabsorption in the proximal tubule; FHHNC, with urinary los...

    journal_title:Seminars in nephrology

    pub_type: 杂志文章,评审

    doi:10.1053/j.semnephrol.2003.08.011

    authors: Knohl SJ,Scheinman SJ

    更新日期:2004-01-01 00:00:00

  • Kidney-pancreas transplantation for diabetic nephropathy.

    abstract::Pancreas transplantation is being performed with increasing frequency and increasing technical success. The availability of new immunosuppressant agents has been associated with a reduction in the previously high rates of allograft rejection in recipients of simultaneous pancreas-kidney transplants. These lower reject...

    journal_title:Seminars in nephrology

    pub_type: 杂志文章,评审

    doi:

    authors: Hricik DE

    更新日期:2000-03-01 00:00:00

  • Apolipoprotein L1 Gene Effects on Kidney Transplantation.

    abstract::The pathogenesis of many common etiologies of nephropathy has been informed by recent molecular genetic breakthroughs. It now is apparent that the ethnic disparity in the risk for nondiabetic chronic kidney disease between African Americans and European Americans is explained largely by variation in the apolipoprotein...

    journal_title:Seminars in nephrology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semnephrol.2017.07.006

    authors: Freedman BI,Locke JE,Reeves-Daniel AM,Julian BA

    更新日期:2017-11-01 00:00:00

  • Monitoring considerations in recombinant human erythropoietin therapy.

    abstract::Effective monitoring of chronic hemodialysis patients treated with recombinant human erythropoietin (r-HuEPO; EPOGEN [epoetin alfa], AMGEN Inc, Thousand Oaks, CA) includes an initial evaluation of the patient, the patient's anemia, and the patient's iron stores. Assessment of iron stores includes obtaining hematocrit ...

    journal_title:Seminars in nephrology

    pub_type: 杂志文章,评审

    doi:

    authors: Ogden DA

    更新日期:1989-03-01 00:00:00

  • Vitamin D analogs: actions and role in the treatment of secondary hyperparathyroidism.

    abstract::Although calcitriol has been shown to have an important role in the pathogenesis of hyperparathyroidism, its use as a therapeutic agent often has been limited by calcemic and phosphatemic toxicity. Vitamin D analogs and the synthetic prohormones, with the potential to have lesser effects on calcium and phosphorus, hav...

    journal_title:Seminars in nephrology

    pub_type: 杂志文章

    doi:10.1016/j.semnephrol.2004.06.013

    authors: Martin KJ,González EA

    更新日期:2004-09-01 00:00:00

  • Xanthine oxidase and uric acid in cardiovascular disease: clinical impact and therapeutic options.

    abstract::The association between increased uric acid (UA) levels and cardiovascular disease (CVD) has been observed and studied for many decades. The value of UA as an independent factor within the metabolic risk profile for prediction of CVD in the normal population remains an issue of ongoing discussion. In turn, increasing ...

    journal_title:Seminars in nephrology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semnephrol.2011.08.007

    authors: Doehner W,Landmesser U

    更新日期:2011-09-01 00:00:00

  • Origin of the glomerular vasculature in the developing kidney.

    abstract::Mechanisms regulating the establishment of the glomerular endothelium and mesangium during glomerulogenesis are not understood. In this article, we discuss two different blood vessel growth processes: vasculogenesis and angiogenesis, with particular attention on how these processes might operate in the developing kidn...

    journal_title:Seminars in nephrology

    pub_type: 杂志文章,评审

    doi:

    authors: Hyink DP,Abrahamson DR

    更新日期:1995-07-01 00:00:00

  • Gadolinium-induced nephrogenic systemic fibrosis.

    abstract::Nephrogenic systemic fibrosis is a new disease whose incidence has peaked and receded over the past decade. It occurs in the presence of significant renal impairment, either acute or chronic (MDRD creatinine clearance of <30 mL/min/1.73 m(2)), and is associated with the administration of gadolinium-based contrast (GBC...

    journal_title:Seminars in nephrology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semnephrol.2011.05.010

    authors: Hellman RN

    更新日期:2011-05-01 00:00:00

  • Update on Chronic Kidney Disease Mineral and Bone Disorder in Cardiovascular Disease.

    abstract::Chronic kidney disease mineral and bone disorder (MBD) encompasses changes in mineral ion and vitamin D metabolism that are widespread in the setting of chronic kidney disease and end-stage renal disease. MBD components associate with cardiovascular disease in many epidemiologic studies. Through impacts on hypertensio...

    journal_title:Seminars in nephrology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semnephrol.2018.08.001

    authors: Lunyera J,Scialla JJ

    更新日期:2018-11-01 00:00:00

  • Pathogenesis and treatment of fluid and electrolyte imbalance in cirrhosis.

    abstract::Patients with cirrhosis have significant abnormalities in their fluid and electrolyte balance, this is manifested mainly by the development of ascites and edema. Ascites is the most common complication of patients with cirrhosis and its development constitutes the first and most important manifestation of the disease....

    journal_title:Seminars in nephrology

    pub_type: 杂志文章,评审

    doi:10.1053/snep.2001.21666

    authors: Cárdenas A,Ginès P

    更新日期:2001-05-01 00:00:00

  • Dialysis equipment and dialysate, past, present and the future.

    abstract::From the beginning of the first described hemodialysis in 1889, history has shown an exponential evolvement of systems that have resulted in greater safety, efficiency, and broader utilization. It took 60 years, 1947, for the technology to be used in a clinical setting in North America, treating acute renal failure. C...

    journal_title:Seminars in nephrology

    pub_type: 历史文章,杂志文章

    doi:

    authors: Van Stone JC

    更新日期:1997-05-01 00:00:00